Development of Inactivated FAKHRAVAC<sup>®</sup> Vaccine against SARS-CoV-2 Virus: Preclinical Study in Animal Models

Development of Inactivated FAKHRAVAC<sup>®</sup> Vaccine against SARS-CoV-2 Virus: Preclinical Study in Animal Models

The recent viral infection disease pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in a global public health crisis. Iran, as one of the countries that reported over five million infected cases by September 2021, has been concerned with the urgent devel...

Full description

Bibliographic Details
Main Authors: Soheil Ghasemi, Kosar Naderi Saffar, Firooz Ebrahimi, Pezhman Khatami, Arina Monazah, Ghorban-Ali Alizadeh, Hossein-Ali Ettehadi, Iman Rad, Shahrzad Nojehdehi, Mousa Kehtari, Fatemeh Kouhkan, Hesam Barjasteh, Sohrab Moradi, Mohammad-Hosein Ghorbani, Ali Khodaeipour, Moslem Papizadeh, Roghayeh Najafi, Ehsan Naghneh, Davood Sadeghi, Ahmad Karimi Rahjerdi
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Vaccines
Subjects:
SARS-CoV-2
vaccine candidate
FAKHRAVAC
COVID-19
Online Access:https://www.mdpi.com/2076-393X/9/11/1271

Internet

https://www.mdpi.com/2076-393X/9/11/1271

Similar Items